Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
GV
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
GV Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
GENE THERAPY.FOR SIGHT.. L E A R N M O R E.
About Science & Services Mission Vision Value Team Company Science & Services Science…
Transforming Life sciences with Artificial Intelligence. Delivering market insights with cutting-edge technology and unparalleled support.
Leyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.
Inertia accelerates clean fusion energy with proven science, expert leadership, and a clear plan to deliver safe, affordable, limitless…
Generate Life Sciences is dedicated to helping more parents have children and access the science they need to protect their family’s…
Overview
Science Focus Leadership Pipeline About We protect sight. UNPARALLELED SCIENCE.
News
Perceive Biotherapeutics Completes Enrollment in Phase 2a JOURNEY Study of VOY-101 Gene Therapy for Geographic Atrophy and Appoints Tony Gibney to Board of Directors
/PRNewswire/ -- Perceive Biotherapeutics, Inc. ("Perceive Bio" or the "Company"), a biotechnology company advancing novel gene therapies in ophthalmology and...
Read more
Report
Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection
/PRNewswire/ -- Perceive Pharma, a pharmaceutical company pioneering novel small molecule therapeutics in ophthalmology, today announced the closing of a $15M...
Read more
Report
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
/PRNewswire/ -- Perceive Biotherapeutics, a biotech company pioneering novel technologies and therapeutics in ophthalmology, today announced the closing of a...
Read more
Report